Literature DB >> 28593449

FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.

W D Leslie1, S R Majumdar2, S N Morin3, L M Lix4, H Johansson5, A Oden5, E V McCloskey5, J A Kanis5,6.   

Abstract

In a large clinical registry for the province of Manitoba, Canada, FRAX predicted incident MOF and hip fracture from 1 to 15 years following baseline assessment. A simple linear rescaling of FRAX outputs seems useful for predicting both short- and long-term fracture risk in this population.
INTRODUCTION: FRAX® estimates 10-year probability of major osteoporotic fracture (MOF) and hip fracture. We examined FRAX predictions over intervals shorter and longer than 10 years.
METHODS: Using a population-based clinical registry for Manitoba, Canada, we identified 62,275 women and 6455 men 40 years and older with baseline dual-energy X-ray absorptiometry scans and FRAX scores. Incident MOF and hip fracture were assessed up to 15 years from population-based data. We assessed agreement between estimated fracture probability from 1 to 15 years using linearly rescaled FRAX scores and observed cumulative fracture probability. The gradient of risk for FRAX probability and incident fracture was examined overall and for 5-year intervals.
RESULTS: FRAX predicted incident MOF and hip fracture for all time intervals. There was no attenuation in the gradient of risk for MOF even for years >10. Gradient of risk was slightly lower for hip fracture prediction in years >10 vs years <5, though HRs remained high. Linear agreement was seen in the relationships between observed vs predicted (rescaled) FRAX probabilities (R 2 0.95-1.00). Among women, there was near-perfect linearity in MOF predictions. Deviations from linearity, with a slightly higher observed than predicted MOF probability, were most evident in the first years following a fracture event and after 10 years for hip fracture prediction in women using FRAX with BMD. Simulations showed that results were robust to large differences in fracture rates and moderate differences in mortality rates.
CONCLUSIONS: FRAX predicts incident MOF and hip fracture up to 15 years and could be adapted to predict fracture over time periods shorter and longer term than 10 years in populations with fracture and mortality epidemiology similar to Canada.

Entities:  

Keywords:  DXA; FRAX; Fracture risk assessment; Osteoporosis; Other analysis/quantitation of bone

Mesh:

Year:  2017        PMID: 28593449     DOI: 10.1007/s00198-017-4091-3

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  32 in total

1.  Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system.

Authors:  N P Roos; E Shapiro
Journal:  Med Care       Date:  1999-06       Impact factor: 2.983

Review 2.  The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women.

Authors:  Robert B Hopkins; Ron Goeree; Eleanor Pullenayegum; Jonathan D Adachi; Alexandra Papaioannou; Feng Xie; Lehana Thabane
Journal:  BMC Musculoskelet Disord       Date:  2011-09-26       Impact factor: 2.362

3.  Competing mortality and fracture risk assessment.

Authors:  W D Leslie; L M Lix; X Wu
Journal:  Osteoporos Int       Date:  2012-06-27       Impact factor: 4.507

4.  Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.

Authors:  L-A Fraser; L Langsetmo; C Berger; G Ioannidis; D Goltzman; J D Adachi; A Papaioannou; R Josse; C S Kovacs; W P Olszynski; T Towheed; D A Hanley; S M Kaiser; J Prior; S Jamal; N Kreiger; J P Brown; H Johansson; A Oden; E McCloskey; J A Kanis; W D Leslie
Journal:  Osteoporos Int       Date:  2010-12-16       Impact factor: 4.507

5.  Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study.

Authors:  S O'Donnell
Journal:  Arch Osteoporos       Date:  2013-06-06       Impact factor: 2.617

6.  Mortality after osteoporotic fractures.

Authors:  O Johnell; J A Kanis; A Odén; I Sernbo; I Redlund-Johnell; C Petterson; C De Laet; B Jönsson
Journal:  Osteoporos Int       Date:  2003-10-30       Impact factor: 4.507

7.  Goal-directed treatment of osteoporosis.

Authors:  Steven R Cummings; Felicia Cosman; Richard Eastell; Ian R Reid; Mona Mehta; E Michael Lewiecki
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

8.  Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks.

Authors:  N D Nguyen; S A Frost; J R Center; J A Eisman; T V Nguyen
Journal:  Osteoporos Int       Date:  2008-03-07       Impact factor: 4.507

9.  Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.

Authors:  Catherine MacLean; Sydne Newberry; Margaret Maglione; Maureen McMahon; Veena Ranganath; Marika Suttorp; Walter Mojica; Martha Timmer; Alicia Alexander; Melissa McNamara; Sheetal B Desai; Annie Zhou; Susan Chen; Jason Carter; Carlo Tringale; Di Valentine; Breanne Johnsen; Jennifer Grossman
Journal:  Ann Intern Med       Date:  2007-12-17       Impact factor: 25.391

10.  External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study.

Authors:  Noa Dagan; Chandra Cohen-Stavi; Maya Leventer-Roberts; Ran D Balicer
Journal:  BMJ       Date:  2017-01-19
View more
  4 in total

1.  Validation of a one year fracture prediction tool for absolute hip fracture risk in long term care residents.

Authors:  Ahmed M Negm; George Ioannidis; Micaela Jantzi; Jenn Bucek; Lora Giangregorio; Laura Pickard; John P Hirdes; Jonathan D Adachi; Julie Richardson; Lehana Thabane; Alexandra Papaioannou
Journal:  BMC Geriatr       Date:  2018-12-27       Impact factor: 3.921

2.  Establishment of a preliminary FRAX®-based intervention threshold for rheumatoid arthritis-associated fragility fracture: a 3-year longitudinal, observational, cohort study.

Authors:  Shan-Fu Yu; Ming-Han Chen; Jia-Feng Chen; Yu-Wei Wang; Ying-Chou Chen; Chung-Yuan Hsu; Han-Ming Lai; Wen-Chan Chiu; Chi-Hua Ko; Hsiao-Ru He; Tien-Tsai Cheng
Journal:  Ther Adv Chronic Dis       Date:  2022-02-25       Impact factor: 5.091

3.  Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States.

Authors:  E Michael Lewiecki; Jesse D Ortendahl; Jacqueline Vanderpuye-Orgle; Andreas Grauer; Jorge Arellano; Jeffrey Lemay; Amanda L Harmon; Michael S Broder; Andrea J Singer
Journal:  JBMR Plus       Date:  2019-05-13

4.  Deterioration of Cortical and Trabecular Microstructure Identifies Women With Osteopenia or Normal Bone Mineral Density at Imminent and Long-Term Risk for Fragility Fracture: A Prospective Study.

Authors:  Roland Chapurlat; Minh Bui; Elisabeth Sornay-Rendu; Roger Zebaze; Pierre D Delmas; Danny Liew; Eric Lespessailles; Ego Seeman
Journal:  J Bone Miner Res       Date:  2019-12-10       Impact factor: 6.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.